Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blueprint Biosecurity is a nonprofit organization dedicated to advancing pandemic prevention by developing actionable roadmaps ("Blueprints") for accelerating and derisking countermeasures against airborne infectious diseases. Their work focuses on evaluating and piloting interventions such as Far-UVC light for indoor air disinfection, next-generation personal protective equipment (PPE), and glycol vapor-based disinfection. They do not conduct clinical trials but instead produce strategic reports and pilot programs to guide public health policy and technology adoption[1][2][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blueprint Biosecurity.